-
1دورية أكاديمية
المؤلفون: Khandekar, Melin J., Banks, Alexander S., Laznik-Bogoslavski, Dina, White, James P., Choi, Jang Hyun, Kazak, Lawrence, Lo, James C., Cohen, Paul, Wong, Kwok-Kin, Kamenecka, Theodore M., Griffin, Patrick R., Spiegelman, Bruce M.
المصدر: Proceedings of the National Academy of Sciences of the United States of America, 2018 Jan . 115(3), 561-566.
الوصول الحر: https://www.jstor.org/stable/26506381Test
-
2دورية أكاديمية
المؤلفون: Zhang, Yang, Deng, Chaoqiang, Ma, Xiao, Gao, Zhendong, Wang, Shengping, Zheng, Qiang, Xia, Guozhan, Wen, Zhexu, Han, Han, Fu, Fangqiu, Liu, Quan, Hu, Hong, Li, Yuan, Wong, Kwok-Kin, Chen, Haiquan
المصدر: Journal of Cancer Research & Clinical Oncology; Sep2020, Vol. 146 Issue 9, p2411-2417, 7p
مصطلحات موضوعية: TREATMENT effectiveness, CANCER chemotherapy, SURGICAL excision, LUNGS, ADENOCARCINOMA, CORNEAL opacity
-
3دورية أكاديمية
المؤلفون: Fillmore, Christine M., Xu, Chunxiao, Desai, Pooja T., Berry, Joanne M., Rowbotham, Samuel P., Lin, Yi-Jang, Zhang, Haikuo, Marquez, Victor E., Hammerman, Peter S., Wong, Kwok-Kin, Kim, Carla F.
المصدر: Fillmore, C. M., C. Xu, P. T. Desai, J. M. Berry, S. P. Rowbotham, Y. Lin, H. Zhang, et al. 2014. “EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumors to TopoII inhibitors.” Nature 520 (7546): 239-242. doi:10.1038/nature14122. http://dx.doi.org/10.1038/nature14122Test.
مصطلحات موضوعية: Lung cancer, EZH2 inhibition, BRG1, EGFR, Chemotherapy, Etoposide
العلاقة: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393352/pdfTest/; Nature